Peri-Implant Health and Perfusion Parameters in Patients After Microvascular Jaw Reconstruction: A Clinical Cohort Study

被引:0
|
作者
Katz, Marie Sophie [1 ]
Ooms, Mark [1 ]
Heitzer, Marius [1 ]
Bock, Anna [1 ]
Vohl, Nils [1 ]
Kniha, Kristian [1 ]
Hoelzle, Frank [1 ]
Modabber, Ali [1 ]
机构
[1] Univ Hosp RWTH Aachen, Dept Oral & Maxillofacial Surg, Aachen, Germany
关键词
laser doppler flowmetry; microvascular flap; perfusion; peri-implant mucositis; peri-implantitis; tissue spectrophotometry; LASER-DOPPLER FLOWMETRY; ONCOLOGY PATIENTS; DENTAL IMPLANTS; TISSUE; REHABILITATION; MANAGEMENT; MUCOSITIS; FLAPS;
D O I
10.1111/cid.70012
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Introduction: The aim of this study was to evaluate perfusion parameters and clinical features of healthy implants and implants affected by peri-implant disease in patients who had undergone microvascular jaw reconstruction. Methods: A total of 25 patients with 92 implants placed in microvascular transplants were included. Of these, 68 implants showed healthy peri-implant tissue, 12 were affected by peri-implant mucositis, and 12 were diagnosed with peri-implantitis. Peri-implant perfusion was measured mesially and distally at the implant shoulder using laser Doppler flowmetry and tissue spectrophotometry (LDF-TS), followed by a clinical evaluation, including measurement of probing depths, bleeding on probing (BOP), plaque index, biotype, type of implant, the restoration and the presence of keratinized tissue. Perfusion parameters were compared between the healthy implants and the implants with peri-implant disease based on the conventional BOP-based diagnosis of peri-implantitis, and the associations between the perfusion values and clinical measurements were analyzed. Optimal cut-off values for predicting peri-implantitis were calculated with receiver operating characteristics. Results: The mean relative amount of hemoglobin and mean blood flow were significantly different between healthy implants and implants with peri-implant mucositis and peri-implantitis (p = 0.003 and p = 0.002, respectively). However, there are interindividual differences that appear to influence blood flow values as well. When a linear mixed regression model was applied, including the patient as a random variable, the difference in blood flow was no longer statistically significant (p = 0.400). Still, the optimal cut-off value of mean blood flow for predicting peri-implantitis was determined to be > 46.5 AU (AUC = 0.788; p < 0.001; CI = 0.695-0.881; sensitivity = 1.00, specificity = 0.60). Conclusion: Implants in microvascular flaps are particularly vulnerable to peri-implant disease. Risk factors are the lack of keratinized peri-implant tissue, fixed restorations, bone-level implants, and high plaque levels. As a noninvasive and objective method, LDF-TS can contribute to risk assessment by evaluating perfusion parameters and help detect the early onset of peri-implant disease.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Evaluation of peri-implant perfusion in patients who underwent avascular augmentation or microvascular reconstruction using laser Doppler flowmetry and tissue spectrophotometry: a prospective comparative clinical study
    Katz, Marie Sophie
    Ooms, Mark
    Winnand, Philipp
    Heitzer, Marius
    Peters, Florian
    Kniha, Kristian
    Hoelzle, Frank
    Modabber, Ali
    CLINICAL ORAL INVESTIGATIONS, 2024, 28 (08)
  • [2] Effects of Peri-implant Mucosal Characteristics on Clinical Peri-implant Parameters: A Retrospective Study
    Bozkurt, Esra
    Uslu, Mustafa Ozay
    MEANDROS MEDICAL AND DENTAL JOURNAL, 2023, 24 (02): : 105 - 111
  • [3] Peri-implant health after microvascular head and neck reconstruction-A retrospective analysis
    Hoffmann, Korbinian Jochen
    Buesch, Christopher
    Moratin, Julius
    Ristow, Oliver
    Hoffmann, Juergen
    Mertens, Christian
    CLINICAL ORAL IMPLANTS RESEARCH, 2024, 35 (02) : 187 - 200
  • [4] Ultrasonographic Tissue Perfusion in Peri-implant Health and Disease
    Barootchi, S.
    Tavelli, L.
    Majzoub, J.
    Chan, H. L.
    Wang, H. L.
    Kripfgans, O. D.
    JOURNAL OF DENTAL RESEARCH, 2022, 101 (03) : 278 - 285
  • [5] Clinical features of peri-implant medication-related osteonecrosis of the jaw: Is there an association to peri-implantitis?
    Troeltzsch, Matthias
    Cagna, David
    Staehler, Philip
    Probst, Florian
    Kaeppler, Gabriele
    Troeltzsch, Markus
    Ehrenfeld, Michael
    Otto, Sven
    JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY, 2016, 44 (12) : 1945 - 1951
  • [6] A study of peri-implant tissue clinical parameters in patients starting anti-osteoporosis medication after existing implant function: a prospective cohort study
    Seki, Keisuke
    Tamagawa, Takaaki
    Yasuda, Hiroyasu
    Manaka, Soichiro
    Akita, Daisuke
    Kamimoto, Atsushi
    Hagiwara, Yoshiyuki
    INTERNATIONAL JOURNAL OF IMPLANT DENTISTRY, 2024, 10 (01)
  • [7] Potential Impact of Microbial Variations After Peri-Implantitis Treatment on Peri-Implant Clinical, Radiographic, and Crevicular Parameters: A Systematic Review
    Di Spirito, Federica
    Pisano, Massimo
    Di Palo, Maria Pia
    Salzano, Flora
    Rupe, Antonio
    Fiorino, Antonino
    Rengo, Carlo
    DENTISTRY JOURNAL, 2024, 12 (12)
  • [8] Levels of procalcitonin in saliva and peri-implant crevicular fluid in patients with peri-implant diseases and health
    Algohar, Ahmed
    Alqerban, Ali
    ARCHIVES OF ORAL BIOLOGY, 2020, 120
  • [9] Diagnostic accuracy of clinical parameters to monitor peri-implant conditions: A matched case-control study
    Monje, Alberto
    Caballe-Serrano, Jordi
    Nart, Jose
    Penarrocha, David
    Wang, Hom-Lay
    Rakic, Mia
    JOURNAL OF PERIODONTOLOGY, 2018, 89 (04) : 407 - 417
  • [10] The Effect of Peri-Implant Therapy on the Expression of Th17-Related Cytokines in Patients with Peri-Implant Mucositis and Peri-Implantitis: A Prospective Longitudinal Study
    Goncalves, Lissya Tomaz da Costa
    Neves, Glaucia Schuindt Teixeira
    da Silva, Alexandre Marques Paes
    Telles, Daniel de Moraes
    Figueredo, Carlos Marcelo da Silva
    Lourenco, Eduardo Jose Veras
    Teixeira, Mayla Kezy Silva
    JOURNAL OF CLINICAL MEDICINE, 2025, 14 (02)